Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine

Infection and Immunity

Volumn 70, Issue 3, 2002, Pages 1507-1517

  Priebe, Gregory P ^a   Brinig, Mary M ^a   Hatano, Kazue ^a   Grout, Martha ^a   Coleman, Fadie T ^a   Pier, Gerald B ^a   Goldberg, Joanna B ^a  

^a CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINO ACID; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; O ANTIGEN; PSEUDOMONAS VACCINE; RECOMBINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DELETION MUTANT; DOSE RESPONSE; DRUG SAFETY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT;

3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE; ADMINISTRATION, INTRANASAL; ALKYL AND ARYL TRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; GENE DELETION; MICE; MICE, INBRED BALB C; MUTATION; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RABBITS; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0036182484     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.3.1507-1517.2002     Document Type: Article

References (60)

1. Acquisition of expression of the P. aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread
2. A complementation analysis of the restriction and modification of DNA in Escherichia coli
3. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
4. Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide
5. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species
6. Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine
7. Analysis and construction of stable phenotypes in gram-negative bacteria with Tn 5 and Tn 10-derived transposons
8. Immunoprophylaxis against Klebsiella and Pseudomonas aeruginosa infections
9. A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung
10. A 25-year study of nosocomial bacteremia in an adult intensive care unit
11. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study
12. Invasion of human epithelial cells by Pseudomonas aeruginosa involves src-like tyrosine kinases p60Src and p59Fyn
13. New immunotype schema for Pseudomonas aeruginosa based on protective antigens
14. Susceptibility of epithelial cells to Pseudomonas aeruginosa invasion and cytotoxicity is upregulated by hepatocyte growth factor
15. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa
16. Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY antimicrobial surveillance program 1997-1999
17. Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI
18. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa
19. Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains
20. Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells
21. Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells
22. Molecular characterization of the Aeromonas hydrophila aroA gene and potential use of an auxotrophic aroA mutant as a live attenuated vaccine
23. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: Application for isolation of unmarked Pseudomonas aeruginosa mutants
24. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: Immunization using divalent flagella preparations
25. The chemical composition of the lipopolysaccharide from Pseudomonas aeruginosa strain PAO and a spontaneously derived rough mutant
26. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts
27. Polysaccharide antigens of Pseudomonas aeruginosa
28. Somatic antigens of Pseudomonas aeruginosa. The structure of O-specific polysaccharide chains of lipopolysaccharides of P. aeruginosa O3 (Lanyi), O25 (Wokatsch) and Fisher immunotypes 3 and 7
29. Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria
30. The extraction and analysis of lipopolysaccharides from Pseudomonas aeruginosa strain PAO and three rough mutants
31. Survey of heat-stable major somatic antigens of Pseudomonas aeruginosa
32. Three new major somatic antigens of Pseudomonas aeruginosa
33. Extending the CD4+ T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar Typhimurium delivery vehicle
34. Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers
35. In vitro T cell-mediated killing of Pseudomonas aeruginosa. I. Evidence that a lymphokine mediates killing
36. In vitro T cell-mediated killing of Pseudomonas aeniginosa. II. The role of macrophages and T cell subsets in T cell killing
37. Suppressor T cells regulating the cell-mediated immune response to Pseudomonas aeruginosa can be generated by immunization with anti-bacterial T cells
38. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa
39. Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody response
40. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model
41. Pseudomonas aeruginosa outer membrane protein F produced in Escherichia coli retains vaccine efficacy
42. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin
43. Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa
44. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung
45. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis
46. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections
47. Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide
48. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide
49. Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein
50. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice
51. Survival in patients with nosocomial pneumonia: Impact of the severity of illness and the etiologic agent
52. Nosocomial infections in medical intensive care units in the United States. National nosocomial infections surveillance system
53. Structure of the core oligosaccharide from the lipopolysaccharide of Pseudomonas aeruginosa PAC1R and its defective mutants
54. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
55. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19
56. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa
57. A broad host range mobilization system for in vivo genetic engineering: Transposon mutagenesis in Gram-negative bacteria
58. Auxotrophic Salmonella typhi as live vaccine
59. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice
60. Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis